Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference41 articles.
1. Review article: hepatitis B and liver transplantation;Mutimer;Aliment Pharmacol Ther,2006
2. The current management of HBV drug resistance;Liaw;J Clin Virol,2005
3. Current treatment of chronic hepatitis B: benefits and limitations;Perrillo;Semin Liver Dis,2005
4. Treatment options in HBV;Craxı`;J Hepatol,2006
5. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine precore mutant study group;Tassopoulos;Hepatology,1999
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HBV and HCV Infection Prophylaxis in Liver Transplant Recipients;Infectious Diseases;2023-12-20
2. Combination Therapy;Hepatitis B Virus and Liver Disease;2021
3. Combination Therapy;Hepatitis B Virus and Liver Disease;2017-09-07
4. Tenofovir disoproxil fumarate monotherapy is superior to entecavir-adefovir combination therapy in patients with suboptimal response to lamivudine-adefovir therapy for nucleoside-resistant HBV: a 96-week prospective multicenter trial;Antiviral Therapy;2017
5. Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment;Clinical and Molecular Hepatology;2016-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3